PARSIPPANY, N.J. – June 10, 2025 – Zoetis Inc., the world’s leading animal health company, will present its latest scientific research on Vetscan Imagyst® artificial intelligence (AI) Urine Sediment Analysis at the ACVIM (American College of Veterinary Internal Medicine) Forum in Louisville, Kentucky, June 19-21, 2025. Zoetis has scheduled two poster sessions, where experts will share new data on how AI-powered detection of urine sediment elements compares to that of board-certified veterinary clinical pathologists.1,2…
Share
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock producers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees.
Contacts
Mike Keeler, Garnett Keeler PR
+44 (0)20 8647 4467mike.keeler@garnettkeeler.com
Charlotte Baker, Garnett Keeler PR
+44 (0)20 8647 4467charlotte.baker@garnettkeeler.com





